{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T09:34:02Z","timestamp":1777109642295,"version":"3.51.4"},"reference-count":42,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2013,5,14]],"date-time":"2013-05-14T00:00:00Z","timestamp":1368489600000},"content-version":"vor","delay-in-days":13,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Internal Medicine Journal"],"published-print":{"date-parts":[[2013,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Like the acute leukaemias, the chronic leukaemias are broadly classified according to their cell lineage of origin. Chronic myeloid leukaemia and chronic lymphocytic leukaemia are the most common disease entities within the myeloid and lymphoid lineages, although several less common entities are well recognised within each broad subgroup. In common with the dramatic progress in the acute leukaemias, there has been considerable progress in our understanding of the biology and molecular genetics of the chronic leukaemias that is now being translated into significant therapeutic advances.<\/jats:p>","DOI":"10.1111\/imj.12135","type":"journal-article","created":{"date-parts":[[2013,5,14]],"date-time":"2013-05-14T08:52:39Z","timestamp":1368521559000},"page":"484-494","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Leukaemias into the 21st century \u2013 part 2: the chronic leukaemias"],"prefix":"10.1111","volume":"43","author":[{"given":"J.","family":"Gibson","sequence":"first","affiliation":[{"name":"Institute of Haematology Royal Prince Alfred Hospital and the University of Sydney  Sydney NSW Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. J.","family":"Iland","sequence":"additional","affiliation":[{"name":"Institute of Haematology Royal Prince Alfred Hospital and the University of Sydney  Sydney NSW Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. R.","family":"Larsen","sequence":"additional","affiliation":[{"name":"Institute of Haematology Royal Prince Alfred Hospital and the University of Sydney  Sydney NSW Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. M. S.","family":"Brown","sequence":"additional","affiliation":[{"name":"Institute of Haematology Royal Prince Alfred Hospital and the University of Sydney  Sydney NSW Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. E.","family":"Joshua","sequence":"additional","affiliation":[{"name":"Institute of Haematology Royal Prince Alfred Hospital and the University of Sydney  Sydney NSW Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,5,14]]},"reference":[{"key":"e_1_2_4_2_1","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissue","author":"Swerdlow S","year":"2008"},{"key":"e_1_2_4_3_1","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1182\/blood.V6.4.372.372","article-title":"Editorial: some speculations on the myeloproliferative syndromes","volume":"6","author":"Dameshek W","year":"1951","journal-title":"Blood"},{"key":"e_1_2_4_4_1","volume-title":"SEER Cancer Statistics Review, 1975\u20132009","author":"Howlader N","year":"2011"},{"key":"e_1_2_4_5_1","first-page":"85","article-title":"Chromosome studies on normal and leukemic human leukocytes","volume":"25","author":"Nowell P","year":"1960","journal-title":"J Natl Cancer Inst"},{"key":"e_1_2_4_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/243290a0"},{"key":"e_1_2_4_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/300765a0"},{"key":"e_1_2_4_8_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.2408149"},{"key":"e_1_2_4_9_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.2406902"},{"key":"e_1_2_4_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4614-3764-2_2"},{"key":"e_1_2_4_11_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200104053441401"},{"key":"e_1_2_4_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa022457"},{"key":"e_1_2_4_13_1","first-page":"1126","article-title":"International randomized study of interferon vs STI571 (IRIS) 8\u2010year follow up: sustained survival and low risk for progression or events in patients with newly diagnosed chronic myeloid leukemia in chronic phase (CML\u2010CP) treated with imatinib","volume":"114","author":"Deininger M","year":"2009","journal-title":"ASH Annu Meet Abstr"},{"key":"e_1_2_4_14_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030513"},{"key":"e_1_2_4_15_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.38.6565"},{"key":"e_1_2_4_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-06-093617"},{"key":"e_1_2_4_17_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.26.3087"},{"key":"e_1_2_4_18_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-01-0092"},{"key":"e_1_2_4_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70233-3"},{"key":"e_1_2_4_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2010.185"},{"key":"e_1_2_4_21_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-12-326405"},{"key":"e_1_2_4_22_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0912614"},{"key":"e_1_2_4_23_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1002315"},{"key":"e_1_2_4_24_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-08-215939"},{"key":"e_1_2_4_25_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.25.0779"},{"key":"e_1_2_4_26_1","volume-title":"ACIM (Australian Cancer Incidence and Mortality) Books","author":"Australian Institute of Health and Welfare (AIHW)","year":"2011"},{"key":"e_1_2_4_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19991215)86:12<2684::AID-CNCR13>3.0.CO;2-V"},{"key":"e_1_2_4_28_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-07-155663"},{"key":"e_1_2_4_29_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa075290"},{"key":"e_1_2_4_30_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-01-0341"},{"key":"e_1_2_4_31_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200012283432602"},{"key":"e_1_2_4_32_1","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2010.1.70"},{"key":"e_1_2_4_33_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI23409"},{"key":"e_1_2_4_34_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-06-093906"},{"key":"e_1_2_4_35_1","unstructured":"HillmenP.Standard & novel treatments in first line and in relapse\/refractory situation.17th Congress of the European Hematology Association Education session. Amsterdam2012."},{"key":"e_1_2_4_36_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-05-224071"},{"key":"e_1_2_4_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61381-5"},{"key":"e_1_2_4_38_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-02-206185"},{"key":"e_1_2_4_39_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.20.8389"},{"key":"e_1_2_4_40_1","unstructured":"MorenoC.Hematopoietic stem cell transplantation for chronic lymphocytic leukemia.17th Congress of the European Hematology Association Education session. Amsterdam2012."},{"key":"e_1_2_4_41_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404441"},{"key":"e_1_2_4_42_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-11-390989"},{"key":"e_1_2_4_43_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.34.7898"}],"container-title":["Internal Medicine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fimj.12135","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/imj.12135","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T23:51:32Z","timestamp":1697327492000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/imj.12135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["10.1111\/imj.12135"],"URL":"https:\/\/doi.org\/10.1111\/imj.12135","archive":["Portico"],"relation":{},"ISSN":["1444-0903","1445-5994"],"issn-type":[{"value":"1444-0903","type":"print"},{"value":"1445-5994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5]]},"assertion":[{"value":"2012-10-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2013-03-11","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2013-05-14","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}